Company Filing History:
Years Active: 2011
Title: Myra Kurtz: Innovator in Synthetic Gene Control
Introduction
Myra Kurtz is a prominent inventor based in Martinsville, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the area of synthetic gene control. Her innovative work has the potential to advance genetic research and applications in various industries.
Latest Patents
Myra Kurtz holds a patent for a synthetic gene control region. This invention provides a synthetic gene control region that comprises a gene regulatory sequence with a binding site for a gene regulatory protein of a yeast strain. Additionally, it includes a promoter from a filamentous fungal strain located downstream of the gene regulatory sequence. The promoter can be recognized by the general transcription factors and RNA polymerase of the yeast strain. The gene regulatory sequence is capable of regulating transcription initiated by the filamentous fungal promoter in the yeast strain. This patent showcases her expertise and innovative approach to genetic engineering.
Career Highlights
Myra Kurtz is currently employed at Merck Sharp & Dohme Corporation, where she continues to contribute to groundbreaking research in biotechnology. Her work at this esteemed company allows her to collaborate with other talented professionals in the field.
Collaborations
Some of her notable coworkers include Janine Bryan and Michelle K Brownlow. Their collaboration fosters a dynamic environment for innovation and research.
Conclusion
Myra Kurtz is a remarkable inventor whose work in synthetic gene control has the potential to impact various scientific fields. Her contributions to biotechnology exemplify the importance of innovation in advancing our understanding of genetics.